NCT07186439Not yet recruiting
Pulmonary Hypertension Screening in Scleroderma
Source: ClinicalTrials.gov · Last updated 24 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Screening for pulmonary hypertension in scleroderma patients
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 35 (estimated)
- First submitted
- 15 Sept 2025
- Start date
- Sept 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Assiut University
- NCT number
- NCT07186439
What you commit to
- Study type: Observational
- Planned participants: 35
- From Sept 2025 to the primary completion date, Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- aga \<18 years
Other
- patients refused to participate
Who the study is looking for
- . Inclusion criteria: aga ≥18 years confirmed diagnosis of scleroderma
Age in the registry: 18 years to 80 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.